Cargando…

Aldosterone Predicts Cardiovascular, Renal, and Metabolic Disease in the General Community: A 4‐Year Follow‐Up

BACKGROUND: We recently reported that normal aldosterone levels are associated with cardiovascular, renal, and metabolic disease in a sample of the US general community (Visit 1). For the current analyses we used the same cohort in a new 4‐year follow‐up study (Visit 2). METHODS AND RESULTS: We meas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Buglioni, Alessia, Cannone, Valentina, Sangaralingham, S. Jeson, Heublein, Denise M., Scott, Christopher G., Bailey, Kent R., Rodeheffer, Richard J., Sarzani, Riccardo, Burnett, John C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2015
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4845260/ https://www.ncbi.nlm.nih.gov/pubmed/26702078 http://dx.doi.org/10.1161/JAHA.115.002505

Ejemplares similares

MANP: a novel particulate guanylyl cyclase A receptor/cGMP activator for resistant hypertension: preliminary first in human clinical trial results
por: Burnett, John C, et al.
Publicado: (2015)

Natriuretic peptide pathways in heart failure: further therapeutic possibilities
por: Sangaralingham, S Jeson, et al.
Publicado: (2022)

C-Type natriuretic peptide: a potential urinary biomarker for renal remodeling and fibrosis during aging
por: Sangaralingham, Jeson S, et al.
Publicado: (2011)

A Human Study to Evaluate Safety, Tolerability, and Cyclic GMP Activating Properties of Cenderitide in Subjects With Stable Chronic Heart Failure
por: Kawakami, Rika, et al.
Publicado: (2018)

Soluble Neprilysin in the General Population: Clinical Determinants and Its Relationship to Cardiovascular Disease
por: Reddy, Yogesh N. V., et al.
Publicado: (2019)

Pro-B-Type natriuretic peptide: a novel, specific biomarker for detection of left ventricular dysfunction in the general community
por: Macheret, Fima, et al.
Publicado: (2009)

C-type natriuretic peptide: the heart’s guardian angel
por: Sangaralingham, S Jeson, et al.
Publicado: (2020)

Antagonizing the renin–angiotensin–aldosterone system in the era of COVID-19
por: Sarzani, Riccardo, et al.
Publicado: (2020)

Cenderitide, a novel dual GC-A and GC-B receptor activator, is a potent chronic cardiorenal fibroinhibiting peptide which suppresses aldosterone and reduces proteinuria in models of ardiorenal fibrosis
por: Martin, Fernando L, et al.
Publicado: (2011)

B-type natriuretic peptide single nucleotide polymorphism rs198389 and survival in the general community
por: Boerrigter, Guido, et al.
Publicado: (2009)

Genetic variants of ANP and cardiometabolic protection: from populations to novel therapeutics
por: Cannone, Valentina, et al.
Publicado: (2013)

Renal Outcomes in Patients with Systolic Heart Failure Treated With Sacubitril-Valsartan or Angiotensin Converting Enzyme Inhibitor/Angiotensin Receptor Blocker
por: Tan, Nicholas Y., et al.
Publicado: (2021)

Aldosterone and Its Blockade: A Cardiovascular and Renal Perspective
por: Lahera, V., et al.
Publicado: (2006)

SAT-541 Difference in Aldosterone Dependency Between Cardiovascular Diseases and Renal Impairments in Patients with Primary Aldosteronism
por: Sone, Masakatsu, et al.
Publicado: (2020)

A novel designer natriuretic peptide CD-NP suppresses TGF-beta 1 induced collagen Type I production in human cardiac fibroblasts
por: Ichiki, Tomoko, et al.
Publicado: (2009)

Early activation of deleterious molecular pathways in the kidney in experimental heart failure with atrial remodeling
por: Ichiki, Tomoko, et al.
Publicado: (2017)

Atrial Natriuretic Peptide: A Molecular Target of Novel Therapeutic Approaches to Cardio-Metabolic Disease
por: Cannone, Valentina, et al.
Publicado: (2019)

EVIDENCE FOR ANGIOTENSIN II AS A NATURALLY EXISTING SUPPRESSOR FOR THE NATRIURETIC PEPTIDE SYSTEM
por: Ma, Xiao, et al.
Publicado: (2023)

Natriuretic Peptides and Blood Pressure Homeostasis: Implications for MANP, a Novel Guanylyl Cyclase a Receptor Activator for Hypertension
por: Cannone, Valentina, et al.
Publicado: (2022)

A Functional Genetic Variant (N521D) in Natriuretic Peptide Receptor 3 Is Associated with Diastolic Dysfunction: The Prevalence of Asymptomatic Ventricular Dysfunction Study
por: Pereira, Naveen L., et al.
Publicado: (2014)

Evidence for Angiotensin II as a Naturally Existing Suppressor for the Guanylyl Cyclase A Receptor and Cyclic GMP Generation
por: Ma, Xiao, et al.
Publicado: (2023)

TRPM7 deficiency exacerbates cardiovascular and renal damage induced by aldosterone-salt
por: Rios, Francisco J., et al.
Publicado: (2022)

B-type natriuretic peptide single nucleotide polymorphism rs198389 is highly prevalent and impacts test characteristics of common assays
por: Costello-Boerrigter, Lisa C, et al.
Publicado: (2009)

M‐Atrial Natriuretic Peptide and Nitroglycerin in a Canine Model of Experimental Acute Hypertensive Heart Failure: Differential Actions of 2 cGMP Activating Therapeutics
por: McKie, Paul M., et al.
Publicado: (2014)

M-atrial natriuretic peptide and nitroglycerin in experimental acute hypertensive heart failure: differential actions of two cGMP activating therapeutics
por: McKie, Paul M, et al.
Publicado: (2013)

STOP-HF Trial: Higher Endogenous BNP and Cardiovascular Protection in Subjects at Risk for Heart Failure
por: Cannone, Valentina, et al.
Publicado: (2021)

Renal effects of Sacubitril/Valsartan in heart failure with reduced ejection fraction: a real life 1-year follow-up study
por: Spannella, Francesco, et al.
Publicado: (2019)

The Atrial Natriuretic Peptide Genetic Variant rs5068 Is Associated With a Favorable Cardiometabolic Phenotype in a Mediterranean Population
por: Cannone, Valentina, et al.
Publicado: (2013)

Association Between Cardiac Natriuretic Peptides and Lipid Profile: a Systematic Review and Meta-Analysis
por: Spannella, Francesco, et al.
Publicado: (2019)

Renal denervation attenuates aldosterone expression and associated cardiovascular pathophysiology in angiotensin II-induced hypertension
por: Hong, Mo-Na, et al.
Publicado: (2016)

Effect of sacubitril/valsartan on renal function: a systematic review and meta‐analysis of randomized controlled trials
por: Spannella, Francesco, et al.
Publicado: (2020)

Cardiac Natriuretic Peptides, Hypertension and Cardiovascular Risk
por: Sarzani, Riccardo, et al.
Publicado: (2017)

Role of Aldosterone and Mineralocorticoid Receptor in Cardiovascular Aging
por: Gorini, Stefania, et al.
Publicado: (2019)

Aldosterone and glomerular filtration – observations in the general population
por: Hannemann, Anke, et al.
Publicado: (2014)

The Relationship Between Renal Stones and Primary Aldosteronism
por: Chang, Chun-Kai, et al.
Publicado: (2022)

Renin, aldosterone, the aldosterone-to-renin ratio, and incident hypertension among normotensive subjects from the general population
por: Arnold, Natalie, et al.
Publicado: (2022)

Aldosterone and Mineralocorticoid Receptor System in Cardiovascular Physiology and Pathophysiology
por: Cannavo, Alessandro, et al.
Publicado: (2018)

Renal Modulation: The Renin-Angiotensin-Aldosterone System (RAAS)
por: Natarajan, Aruna, et al.
Publicado: (2008)

A Novel Aldosterone Antagonist Limits Renal Injury in 5/6 Nephrectomy
por: Fujihara, Clarice K., et al.
Publicado: (2017)

FRI143 Serum Aldosterone Levels Predict Decline In Renal Function After Unilateral Adrenalectomy For Primary Aldosteronism
por: Stumpf, Matheo A M, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_bojtpfnfdt9l8dqevbkalpnjc0